PD-L1 and LAG3 Expression in Hepatocellular Carcinoma Associated with HCV and Steatohepatitis

被引：0
|
作者：
Xing, Dongmei
Luan, Lan
Zhu, Qingfeng
Gani, Faiz
Pawlik, Timothy
Taube, Janis M.
Anders, Robert A.
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Johns Hopkins Univ, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1707
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [21] PD-L1/PD-1 In Hepatocellular Carcinoma: An Institutional Review
    Poveda, Julio
    Duarte, Melissa
    Jones, Patricia Denise
    Chowdhury, Aneesa
    Brown, Kevin
    Garcia-Buitrago, Monica
    LABORATORY INVESTIGATION, 2019, 99
  • [22] PD-L1/PD-1 In Hepatocellular Carcinoma: An Institutional Review
    Poveda, Julio
    Duarte, Melissa
    Jones, Patricia Denise
    Chowdhury, Aneesa
    Brown, Kevin
    Garcia-Buitrago, Monica
    MODERN PATHOLOGY, 2019, 32
  • [23] Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model
    Panpan kong
    Huan Yang
    Qing Tong
    Xiaogang Dong
    Mamumaimaitijiang-Abula Yi
    Dong Yan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10685 - 10700
  • [24] Impact of lymphocyte-to-monocyte ratio on tumor progression in hepatocellular carcinoma associated with PD-L1 expression
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Shimokawa, Masahiro
    Mano, Yohei
    Motomura, Takashi
    Toshima, Takeo
    Harada, Noboru
    Harimoto, Norifumi
    Ikegami, Toru
    Soejima, Yuji
    Maehara, Yoshihiko
    CANCER SCIENCE, 2018, 109 : 905 - 905
  • [25] Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model
    Kong, Panpan
    Yang, Huan
    Tong, Qing
    Dong, Xiaogang
    Yi, Mamumaimaitijiang-Abula
    Yan, Dong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10685 - 10700
  • [26] PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component
    Tanigawa, Masahiko
    Naito, Yoshiki
    Akiba, Jun
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Ishida, Yusuke
    Ishikawa, Hiroto
    Hisaka, Toru
    Fujita, Fumihiko
    Yasunaga, Masafumi
    Shigaki, Takahiro
    Sudo, Tomoya
    Mihara, Yutaro
    Nakayama, Masamichi
    Kondo, Reiichiro
    Kusano, Hironori
    Shimamatsu, Kazuhide
    Okuda, Koji
    Akagi, Yoshito
    Yano, Hirohisa
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (12) : 2069 - 2074
  • [27] Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma
    Guo, Rui
    Rao, Pan-guo
    Liao, Bao-zhen
    Luo, Xin
    Yang, Wen-wen
    Lei, Xing-heng
    Ye, Jun-ming
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [28] Tumor–stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma
    Dong Wang
    Jia Luo
    YiMing Tao
    BMC Cancer, 23
  • [29] PD-L1 expression on circulating tumor cells in patients with hepatocellular carcinoma.
    Kim, Hee Yeon
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Significance of PD-L1 clones and C-MET expression in hepatocellular carcinoma
    Chun, Hyung-Wook
    Hong, Ran
    ONCOLOGY LETTERS, 2019, 17 (06) : 5487 - 5498
12345